🕵️ Medicus Pharma Ltd. ($MDCX)
SEC insider & ownership activity, last 12 months · CIK 1997296 · every row links its SEC filing
Insiders were quiet over the last 12 months – no open-market buys or sells. 2 red-flag 8-Ks in the window, most recently Delisting notice (3.01), May 20, 2026.
Insider flow
0 buyers, $0 (0 lots) · 0 sellers, $0 (0 lots)
No open-market insider transactions in the last 12 months.
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Kenneth R. Melani | 18.2% | 13G | Aug 12, 2025 | filing ↗ | |
| Ajay Raju | 16.9% | 13G | Jan 13, 2025 | filing ↗ | |
| Velocity Fund Partners, LP | 15.9% | 13G | Aug 12, 2025 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Shareholder vote (5.07) | Jun 3, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 3, 2026 | filing ↗ |
| Material agreement (1.01) | May 20, 2026 | filing ↗ |
| New financial obligation (2.03) | May 20, 2026 | filing ↗ |
| Delisting notice (3.01) | May 20, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 20, 2026 | filing ↗ |
| Material agreement (1.01) | Apr 21, 2026 | filing ↗ |
| Delisting notice (3.01) | Apr 21, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 21, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Mar 5, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 5, 2026 | filing ↗ |
| Material agreement (1.01) | Dec 29, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 29, 2025 | filing ↗ |
| Material agreement (1.01) | Dec 5, 2025 | filing ↗ |
| Unregistered equity sale (3.02) | Dec 5, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Dec 5, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 5, 2025 | filing ↗ |
| Officer/director changes (5.02) | Nov 28, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Nov 28, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 28, 2025 | filing ↗ |
| Other events (8.01) | Nov 14, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 14, 2025 | filing ↗ |
| Unregistered equity sale (3.02) | Oct 16, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 16, 2025 | filing ↗ |
| Material agreement (1.01) | Sep 17, 2025 | filing ↗ |
| New financial obligation (2.03) | Sep 17, 2025 | filing ↗ |
| Other events (8.01) | Sep 17, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 17, 2025 | filing ↗ |
| Officer/director changes (5.02) | Sep 12, 2025 | filing ↗ |
| Acquisition or disposition (2.01) | Aug 29, 2025 | filing ↗ |